Expand EYPT Menu
EYPT MENU

EYPT Stock Summary and Trading Ideas (Eyepoint | NASDAQ:EYPT)

Charts for Today's Stock Price and Implied Volatility in Eyepoint

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for EYPT by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Eyepoint (EYPT) Frequently Asked Questions

What does Eyepoint do?

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

What symbol and exchange does Eyepoint shares trade?

Eyepoint trades on the NASDAQ stock market under the symbol EYPT.

What is Eyepoint stock price doing today?

As of April 24, 2026, EYPT stock price declined to $13.77 with 577,054 million shares trading.

What is Eyepoint's Beta?

EYPT has a beta of 2.36, meaning it tends to be more sensitive to market movements. EYPT has a correlation of 0.18 to the broad based SPY ETF.

How much is Eyepoint worth?

EYPT has a market cap of $1.11 billion. This is considered a Small Cap stock.

How much money does Eyepoint make?

Last quarter Eyepoint reported $620,000 in Revenue and -$.81 earnings per share. This fell short of revenue expectation by $-199,480 and missed earnings estimates by -$.05.

What is the highest and lowest price Eyepoint traded in the last 3 year period?

In the last 3 years, EYPT traded as high as $30.99 and as low as $3.91.

What are the top ETFs holding Eyepoint?

The top ETF exchange traded funds that EYPT belongs to (by Net Assets): VTI, IWM, VXF, IWN, XPH.

Is Eyepoint (EYPT) a good investment?

EYPT has outperformed the market in the last year with a return of +105.2%, while the SPY ETF gained +34.7%. However, in the most recent history, EYPT shares have underperformed the stock market with its stock returning -9.3% in the last 3 month period and -3.2% for the last 2 week period, while SPY has returned +3.8% and +5.0%, respectively.

What are the support and resistance levels for Eyepoint (EYPT)?

EYPT support price is $13.32 and resistance is $14.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EYPT shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes